QIAGEN IPA
Identifying novel drug targets in paraganglioma
185 views
If you'd like to explore a new way to identify potential new drug targets, you won't want to miss this unique opportunity to learn from industry experts about:
How ML used known relationships in the QKG to infer hidden relationships between potential targets and diseases
A library of 1500 disease networks available in QIAGEN Ingenuity Pathway Analysis (IPA)
MicroMatrices' research into paraganglioma and evaluation of novel gene associations predicted by our disease network
Opportunities to verify new drug targets for paraganglioma as well as potential targets in other diseases
Related videos
QIAGEN IPA
Analyze, compare and contextualize your biological data with QIAGEN IPA
Discover why QIAGEN Ingenuity Pathway Analysis (IPA) is more than just...
QIAGEN IPA
Interpreting your comparison analyses results in IPA
Learn how to view and interpret your comparison analyses results in IPA and...
QIAGEN IPA
Interpreting the Results of Your Phosphoproteomics Analysis in IPA
Learn how to view and interpret your Phosphoproteomics Analysis results in...
QIAGEN IPA
New user training: QIAGEN Ingenuity Pathway Analysis (IPA)
New user training: Large dataset analysis and knowledge base queries using...